Literature DB >> 19634707

The Yin-Yang of TNFalpha in the guinea pig model of tuberculosis.

Lan H Ly1, David N McMurray.   

Abstract

Tumour necrosis factor alpha (TNF-alpha) is a prototypic pro-inflammatory cytokine that has a central role in the initial host response to Mycobacterium tuberculosis infection. It is a key player in granuloma formation, macrophage activation, bacterial killing, and pathology in vivo. However, the exact mechanism has not been completely understood. This review summarizes the TNFalpha data acquired from the 'gold standard' guinea pig animal model of tuberculosis. While production of TNFalpha is widely accepted as beneficial to the host response, we have found that this hypothesis is just one side of the story. TNFalpha can up-regulate and down-regulate some key pro-inflammatory cytokines (IFNgamma, IL-12p40) and differentially modulate macrophage activation and intracellular bacterial growth. Neutralization of TNFalpha in vivo allows an antiinflammatory TGFbeta-mediated response to develop. Furthermore, BCG vaccination modulates TNFalpha responses directly in the pulmonary granulomas to reduce tissue damage. The bipolar nature of TNFalpha should be considered as knowledge of this critical molecule continues to grow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634707

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  7 in total

1.  The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs.

Authors:  Lee G Klinkenberg; Jong-Hee Lee; William R Bishai; Petros C Karakousis
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Jerome B Zeldis; George Muller; Gilla Kaplan
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 4.  Tuberculosis: what we don't know can, and does, hurt us.

Authors:  David G Russell; Clifton E Barry; JoAnne L Flynn
Journal:  Science       Date:  2010-05-14       Impact factor: 47.728

5.  Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Veronique Dartois; George Muller; Gilla Kaplan
Journal:  PLoS Pathog       Date:  2011-09-15       Impact factor: 6.823

Review 6.  Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.

Authors:  Dilara Kiran; Brendan K Podell; Mark Chambers; Randall J Basaraba
Journal:  Semin Immunopathol       Date:  2015-10-28       Impact factor: 9.623

7.  A humanized mouse model of tuberculosis.

Authors:  Veronica E Calderon; Gustavo Valbuena; Yenny Goez; Barbara M Judy; Matthew B Huante; Putri Sutjita; R Katie Johnston; D Mark Estes; Robert L Hunter; Jeffrey K Actor; Jeffrey D Cirillo; Janice J Endsley
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.